Scarica l'app Stockscreener
34.89
2.01%
-0.734
Precedente Chiudi:
$35.62
Aprire:
$35.39
Volume 24 ore:
72,904
Relative Volume:
0.06
Capitalizzazione di mercato:
$3.05B
Reddito:
$23.38M
Utile/perdita netta:
$-155.22M
Rapporto P/E:
-15.93
EPS:
-2.19
Flusso di cassa netto:
$-134.36M
1 W Prestazione:
+0.68%
1M Prestazione:
+9.56%
6M Prestazione:
+75.49%
1 anno Prestazione:
+27.58%
Intervallo 1D:
$34.71
$35.62
Intervallo di 1 settimana:
$34.50
$36.55
Portata 52W:
$13.45
$36.55
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Nome
Ideaya Biosciences Inc
Settore
Industria
Telefono
650-443-6209
Indirizzo
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Confronta IDYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
34.82 | 3.12B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.64 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.04 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.25 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
890.01 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.74 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-09-04 | Iniziato | Barclays | Overweight |
| 2025-09-04 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Iniziato | TD Cowen | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-06-26 | Iniziato | Wells Fargo | Overweight |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-11-05 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Iniziato | Mizuho | Outperform |
| 2024-03-08 | Iniziato | BTIG Research | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Outperform |
| 2023-05-24 | Iniziato | Goldman | Buy |
| 2023-04-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-23 | Iniziato | Berenberg | Buy |
| 2023-02-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-28 | Iniziato | CapitalOne | Overweight |
| 2022-10-27 | Iniziato | Citigroup | Buy |
| 2022-08-15 | Downgrade | Stifel | Buy → Hold |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2022-03-10 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-11 | Iniziato | Guggenheim | Buy |
| 2020-10-07 | Iniziato | Wedbush | Outperform |
| 2020-09-01 | Iniziato | Northland Capital | Outperform |
| 2020-07-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-06 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-13 | Iniziato | ROTH Capital | Buy |
| 2019-10-17 | Iniziato | Oppenheimer | Outperform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-17 | Iniziato | Citigroup | Buy |
| 2019-06-17 | Iniziato | JP Morgan | Neutral |
| 2019-06-17 | Iniziato | Jefferies | Buy |
Mostra tutto
Ideaya Biosciences Inc Borsa (IDYA) Ultime notizie
IDEAYA Biosciences stock rises after FDA clearance for bispecific ADC By Investing.com - Investing.com Nigeria
IDEAYA Biosciences stock rises after FDA clearance for bispecific ADC - Investing.com
IDEAYA Biosciences Announces IND Clearance for IDE034, a Potenti - GuruFocus
IDEAYA receives FDA clearance for bispecific cancer drug IDE034 By Investing.com - Investing.com Australia
IDEAYA Biosciences Gets FDA Clearance to Begin Phase 1 Trial of IDE034 in Early 2026 - MarketScreener
Ideaya Biosciences announces clearance for IDE034 - MarketScreener
Ideaya Biosciences Announces Clearance For IDE034 - TradingView
IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types - Yahoo Finance
A Closer Look at IDEAYA Biosciences (IDYA) Valuation as Investor Optimism Builds - Yahoo Finance
(IDYA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Ideaya Biosciences announces inducement grants under Nasdaq listing rule - TipRanks
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Santa Maria Times
IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events - Sahm
How sustainable is IDEAYA Biosciences Inc. stock dividend payoutJuly 2025 Decliners & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ
Ideaya Biosciences: Primed For SuccessMajor Eye Cancer Catalyst Weeks Away (IDYA) - Seeking Alpha
Ideaya Biosciences stock reaches 52-week high of 35.13 USD By Investing.com - Investing.com India
Ideaya Biosciences stock reaches 52-week high of 35.13 USD - Investing.com
Is IDEAYA Biosciences Inc 30J a good long term investmentDividend Aristocrats List & Build Balanced Portfolio - earlytimes.in
Truist Securities initiates coverage on Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com South Africa
IDEAYA Biosciences Turns a Profit in Q3 on Servier Partnership Revenue - MSN
Ideaya Biosciences: A Promising Investment as Key Clinical Data Nears - Ad-hoc-news.de
Truist Securities initiates coverage on Ideaya Biosciences stock with Buy rating - Investing.com Canada
IDEAYA Biosciences (NASDAQ: IDYA) at 2025 Citi and Evercore investor events - Stock Titan
EBITDA per share of IDEAYA Biosciences, Inc. – DUS:30J - TradingView
What analysts say about IDEAYA Biosciences Inc stockEarnings Season Recap & Unlock Smart Investment Tactics That Work - earlytimes.in
How higher bond yields impact IDEAYA Biosciences Inc. (30J) stockWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Published on: 2025-11-20 07:13:14 - newser.com
Why IDEAYA Biosciences Inc. (30J) stock appears on watchlists2025 Market Overview & Risk Managed Trade Strategies - newser.com
What valuation multiples suggest for IDEAYA Biosciences Inc. stockQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
Will IDEAYA Biosciences Inc. (30J) stock top growth indexesWeekly Gains Report & Detailed Earnings Play Strategies - newser.com
Using AI based signals to follow IDEAYA Biosciences Inc.Market Trend Report & Fast Momentum Stock Entry Tips - newser.com
Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimates2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
How IDEAYA Biosciences Inc. stock reacts to Fed rate cutsEarnings Risk Summary & Real-Time Price Movement Reports - newser.com
Will IDEAYA Biosciences Inc. stock see PE expansionGap Up & Weekly Chart Analysis and Trade Guides - newser.com
Will IDEAYA Biosciences Inc. (30J) stock profit from automation waveMarket Trend Report & Reliable Intraday Trade Alerts - newser.com
Published on: 2025-11-19 05:21:38 - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth storyWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
Published on: 2025-11-19 03:26:31 - newser.com
Why retail investors pile into IDEAYA Biosciences Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Jefferies Global Healthcare Conference - MarketScreener
IDEAYA Biosciences, Inc. (IDYA) AI-Powered Stock Analysis - Meyka
Ideaya Biosciences Inc Azioni (IDYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):